Fatty liver is independently associated with increased cardiovascularrisk in the presence of metabolic dysfunction

Background While metabolic dysfunction-associated fatty liver disease (MAFLD) has recently been proposed as positive diagnosis to substitute (non)-alcoholic fatty liver disease applying novel and broad criteria for metabolic dysfunction, it is yet unclear if this definition is more accurate in identifying MAFLD patients at increased cardiovascular risk compared to those with metabolic dysfunction without fatty liver (FL).